title: Neuroendocrine implications of opioid therapy.
abstract: Opioid analgesics are given to people with pain. These medications are highly effective for relieving pain and are generally considered to have little or no end-organ toxi-cities. Although they are generally feared because of their potential for abuse, diversion, and psychological dependence, little attention is given to their neuroendocrine consequences. They are known to have central nervous systems effects and are now understood to impact the regulation of gonadotropic hormones. Providing meaningful informed consent requires disclosure about the risks associated with lowered gonadotropic hormone levels.
authors: American Society of Pain Educators, 7 Oak Place, Suite 7, Montclair, NJ 07042, USA. drcole@paineducators.org
authors: B Eliot
authors: BE
authors: Cole
mesh_terms: D000701:Analgesics, Opioid / Q000009:adverse effects / Q000494:pharmacology*; D006801:Humans; D007006:Hypogonadism / Q000139:chemically induced; D009490:Neurosecretory Systems / Q000187:drug effects*
chemical_list: D000701:Analgesics, Opioid